Politics, Policy & Law
Abernethy’s appointment sheds light on Verily’s plans
Verily to develop clinical research tools, conduct research for itself and others
Verily is planning to develop clinical research tools and conduct research for itself and others.
Verily’s hiring of Amy Abernethy, who recently stepped down as FDA’s principal deputy commissioner, sheds some light on the company’s plans for its healthcare businesses, including conducting clinical trials for itself and for life sciences companies, and developing and selling